Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.

MLA

Ye, Guo-Jie, et al. “Safety and Biodistribution Evaluation of RAAV2tYF-CB-HRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.” Human Gene Therapy. Clinical Development, vol. 26, no. 3, Sept. 2015, pp. 177–84. EBSCOhost, https://doi.org/10.1089/humc.2015.077.

APA

Ye, G.-J., Conlon, T., Erger, K., Sonnentag, P., Sharma, A. K., Howard, K., Knop, D. R., & Chulay, J. D. (2015). Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice. Human Gene Therapy. Clinical Development, 26(3), 177–184. https://doi.org/10.1089/humc.2015.077

Chicago

Ye, Guo-Jie, Thomas Conlon, Kirsten Erger, Peter Sonnentag, Alok K Sharma, Kellie Howard, David R Knop, and Jeffrey D Chulay. 2015. “Safety and Biodistribution Evaluation of RAAV2tYF-CB-HRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.” Human Gene Therapy. Clinical Development 26 (3): 177–84. doi:10.1089/humc.2015.077.